Trials / Unknown
UnknownNCT05701501
Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
Clinical Study of Vitamin B5 in Adjuvant Treatment of Inflammatory Bowel Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Patients with IBD are randomized to oral administration of vitamin B5 and placebo based on the standard treatment, exploring whether Vitamin B5 can increase the clinical remission rate of IBD patients and improve the treatment effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin B5 Tablets | The experimental group was given Vitamin tablets (5mg/tablet) based on the standard IBD treatment. |
| DRUG | placebo | The control group was given placebo tablets of the same type based on the standard IBD treatment. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-02-01
- Completion
- 2024-02-01
- First posted
- 2023-01-27
- Last updated
- 2023-06-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05701501. Inclusion in this directory is not an endorsement.